Raymond James Has Lowered Expectations for DRI Healthcare Trust (TSE:DHT.UN) Stock Price

DRI Healthcare Trust (TSE:DHT.UN) had its target price trimmed by Raymond James from C$23.00 to C$22.00 in a research report released on Wednesday,BayStreet.CA reports.

Other research analysts also recently issued research reports about the stock. Scotiabank lifted their price objective on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Truist Financial cut their price target on shares of DRI Healthcare Trust from C$17.00 to C$14.00 in a report on Thursday, July 25th. One analyst has rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, DRI Healthcare Trust presently has an average rating of “Moderate Buy” and an average target price of C$18.00.

DRI Healthcare Trust Trading Up 37.9 %

DHT.UN opened at C$13.20 on Wednesday. The business’s 50-day moving average is C$13.27 and its two-hundred day moving average is C$13.64. DRI Healthcare Trust has a 1 year low of C$10.39 and a 1 year high of C$17.43.

DRI Healthcare Trust Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, October 18th. Investors of record on Friday, October 18th were paid a $0.085 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.34 dividend on an annualized basis and a yield of 2.58%. DRI Healthcare Trust’s dividend payout ratio (DPR) is -920.00%.

About DRI Healthcare Trust

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.